New CRISPR Tools to Correct Pathogenic Mutations in Usher Syndrome.

Abstract excerpt

Inherited retinal degenerations are a leading cause of blindness in the UK. Significant advances have been made to tackle this issue in recent years, with a pioneering FDA approved gene therapy treatment (Luxturna®), which targets a loss of function mutation in the RPE65 gene. However, there remain notable shortcomings to this form of gene replacement therapy. In particular, the lack of viability for gene...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adolescent
• Share to Clustered Regularly Interspaced Short Palindromic Repeats